Clinical Trials Browser

OTHER_GOV × Interventional × Hypersensitivity × Clear all

NCT01837693 2025-06-26

NTCC2

Phase NA Completed

41,127 enrolled

GynecologicOther neoplasm

Uterine Cervical Neoplasms, Hypersensitivity, Neoplasms, Precancerous Conditions

NCT01673906 2025-06-24

68-Ga-labeled Octreotide Analogues PET in Duodenal-pancreatic Neuroendocrine Tumours

Phase 2 Completed

Hypersensitivity, Neuroendocrine Tumors

NCT02349763 2020-10-23

DEPARO

Phase 3 Completed

Hypersensitivity